$AMGN
-
Markets
Amgen’s Strategic Position Amid Market Fluctuations and Competitive Pressures
$AMGN Amgen (NASDAQ: AMGN) recently faced market scrutiny after its new weight-loss drug met, but did not exceed, Wall Street’s…
Read More » -
Markets
Navigating The Future: Amgen And Rivian Forge Ahead Amidst Industry Challenges And Innovations
$AMGN, $RIVN In the dynamic landscapes of biotechnology and automotive industries, two companies, Amgen and Rivian Automotive, stand out for…
Read More » -
Markets
Navigating The Pharmaceutical Landscape: A Close Look At Eli Lilly, Expedia And Amgen
$LLY, $EXPE, $AMGN In the dynamic world of pharmaceuticals and biotechnology, companies like Eli Lilly and Company (NYSE:LLY), Expedia Group,…
Read More » -
Markets
Amgen Reports Robust First Quarter 2024 Financial Performance Amidst Expanding Product Portfolio
$AMGN Amgen (NASDAQ:AMGN) today unveiled its financial outcomes for the first quarter of 2024, marking a period of significant growth…
Read More »